Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain

13 août 2019 mis à jour par: Defense and Veterans Center for Integrative Pain Management

A Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain

Using a retrospective review of records, we will conduct a multivariate analysis to examine the relationship between exposure to ketamine, as an analgesic agent in combat related trauma care, the use of additional opioid pain medications, and patient reported pain levels.

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Description détaillée

This is a retrospective study to determine if there is a relationship between intravenous infusion of ketamine given for analgesia and the use of additional opioid pain medications and patient reported pain levels before and during ketamine usage. The investigator anticipates that records of up to 700 subjects will be reviewed for eligibility. The time period 24 hours before the initial ketamine therapy is initiated along with 24 & 48 hours after the start of ketamine therapy will be the time periods examined. The average/minimum/maximum pain scores during these time periods will be used. Medication usage will be calculated over the 24 hour time periods.

This protocol is presented as an initial step in exploring the possible relationship between the administration of ketamine as an analgesic agent, the potential reduction in pain medications, and the potential reduction of pain levels. With this the goals/objectives are as follows:

Objectives

  1. To compare morphine consumption in battlefield injured patients with acute pain 24 hours before the initiation of a ketamine infusion to the subsequent 48 hours following the start of infusion.
  2. To compare average/minimum/maximum pain scores in battlefield injured patients with acute pain 24 hours before the initiation of a ketamine infusion to the subsequent 48 hours following the start of infusion.
  3. To describe the pain trajectory in battlefield injured patients with acute pain after the initiation of ketamine infusions.
  4. To measure the absolute and proportional incidence of ketamine associated side effects in battlefield injured patients with acute pain following the initiation of ketamine infusions.

Type d'étude

Observationnel

Inscription (Réel)

80

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

  • États-Unis
    • Maryland
      • Bethesda, Maryland, États-Unis, 20889
        • Walter Reed National Military Medical Center

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon de probabilité

Population étudiée

Male and female military health care beneficiaries age 18 years and older

La description

Inclusion Criteria:

  • Battlefield injured from January 2007 to December 2013
  • Prescribed a ketamine infusion for acute pain
  • Awake, alert (non intubated/sedated), and able to report pain scores 24 hours prior to the start of infusion and up to 48 hours following infusion

Exclusion Criteria:

  • Patients who did not receive an injury in theater and did not receive ketamine while being treated by the APS or WRNMMC/WRAMC hospital staff
  • No continuous perineural catheter or epidural placement while on ketamine infusion
  • Less than 18 years old

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Battlefield Injury with ketamine treatment
Patients who received ketamine infusions to treat pain from January 2007 to December 2013.
Médicament: kétamine

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Opioid consumption measured in morphine equivalents
Délai: 24 hours before ketamine infusion
Amount of opioids consumed within time frame
24 hours before ketamine infusion
Opioid consumption measured in morphine equivalents
Délai: 24 hours after ketamine infusion
Amount of opioids consumed within time frame
24 hours after ketamine infusion
Opioid consumption measured in morphine equivalents
Délai: 48 hours after ketamine infusion
Amount of opioids consumed within time frame
48 hours after ketamine infusion
Pain scores
Délai: 24 hours before ketamine infusion

Defense and Veterans Pain Rating Scale Pain scores recorded based on the Defense and Veterans Pain Rating Scale

Rate the severity of your CURRENT pain:

0 - No Pain

  1. - Hardly notice pain
  2. - Notice pain, does not interfere with activities
  3. - Sometimes distracts me
  4. - Distracts me, can do usual activities
  5. - Interrupts some activities
  6. - Hard to ignore, avoid usual activities
  7. - Focus of attention, prevents doing daily activities
  8. - Awful, hard to do anything
  9. - Can't bear pain, unable to do anything
  10. - As bad as it could be, nothing else matters

Circle the number that describes how, during the past 24 hours, pain has interfered with your usual activity:

0 - 10 (0=does not interfere, 10=completely interferes)

Circle the number that describes how, during the past 24 hours, pain has interfered with sleep:

0 - 10 (0=does not interfere, 10=completely interferes) Circle the number that describes how, during the past 24 hours, pain has affected your mood: 0-10
24 hours before ketamine infusion
Pain scores
Délai: 24 hours after ketamine infusion

Defense and Veterans Pain Rating Scale Pain scores recorded based on the Defense and Veterans Pain Rating Scale

Rate the severity of your CURRENT pain:

0 - No Pain

  1. - Hardly notice pain
  2. - Notice pain, does not interfere with activities
  3. - Sometimes distracts me
  4. - Distracts me, can do usual activities
  5. - Interrupts some activities
  6. - Hard to ignore, avoid usual activities
  7. - Focus of attention, prevents doing daily activities
  8. - Awful, hard to do anything
  9. - Can't bear pain, unable to do anything
  10. - As bad as it could be, nothing else matters

Circle the number that describes how, during the past 24 hours, pain has interfered with your usual activity:

0 - 10 (0=does not interfere, 10=completely interferes)

Circle the number that describes how, during the past 24 hours, pain has interfered with sleep:

0 - 10 (0=does not interfere, 10=completely interferes) Circle the number that describes how, during the past 24 hours, pain has affected your mood: 0-10
24 hours after ketamine infusion
Pain scores
Délai: 48 hours after ketamine infusion

Defense and Veterans Pain Rating Scale Pain scores recorded based on the Defense and Veterans Pain Rating Scale

Rate the severity of your CURRENT pain:

0 - No Pain

  1. - Hardly notice pain
  2. - Notice pain, does not interfere with activities
  3. - Sometimes distracts me
  4. - Distracts me, can do usual activities
  5. - Interrupts some activities
  6. - Hard to ignore, avoid usual activities
  7. - Focus of attention, prevents doing daily activities
  8. - Awful, hard to do anything
  9. - Can't bear pain, unable to do anything
  10. - As bad as it could be, nothing else matters

Circle the number that describes how, during the past 24 hours, pain has interfered with your usual activity:

0 - 10 (0=does not interfere, 10=completely interferes)

Circle the number that describes how, during the past 24 hours, pain has interfered with sleep:

0 - 10 (0=does not interfere, 10=completely interferes) Circle the number that describes how, during the past 24 hours, pain has affected your mood: 0-10
48 hours after ketamine infusion
Number of ketamine side effects
Délai: 24 hours before ketamine infusion
Recorded side effects after ketamine infusion
24 hours before ketamine infusion
Number of ketamine side effects
Délai: 24 after ketamine infusion
Recorded side effects after ketamine infusion
24 after ketamine infusion
Number of ketamine side effects
Délai: 48 hours after ketamine infusion
Recorded side effects after ketamine infusion
48 hours after ketamine infusion

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Defense and Veterans Center for Integrative Pain Management

Les enquêteurs

  • Chercheur principal: Michael Kent, MD, Walter Reed National Military Medical Center

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 août 2014

Achèvement primaire (Réel)

1 août 2017

Achèvement de l'étude (Réel)

30 août 2017

Dates d'inscription aux études

Première soumission

12 août 2019

Première soumission répondant aux critères de contrôle qualité

13 août 2019

Première publication (Réel)

15 août 2019

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

15 août 2019

Dernière mise à jour soumise répondant aux critères de contrôle qualité

13 août 2019

Dernière vérification

1 août 2019

Plus d'information

Termes liés à cette étude

Mots clés

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • 399623

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner